Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer

A Feasibility Study of Patient Comfort and Dosimetry Evaluation in Prone Breast Radiotherapy.

Status

Terminated

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02704312

Acronym

PROCUBITUS

Enrollment

Registered

2016-03-10

Start date

2015-11-30

Completion date

2022-02-11

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

Compare dosimeters in both positions (prone and decubitus) for each patient

Detailed description

Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk. The technique used is that of which the dose on the organs at risk is as low as possible, and whose dose to the target volume is the closest possible to the prescribed dose (100% of the prescribed dose).

Interventions

RADIATIONRadiotherapy by Prone and decubitus

Dosimetric comparison of doses in target volumes and organs at risk

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients with primary breast cancer and in whom conservative post- surgery radiation therapy for breast cancer is prescribed. * Patients aged over 18 years * Patients with indication for conservative surgery. * Resection should be in healthy margin. * Women of childbearing potential must satisfy a negative pregnancy test at the screening visit and use effective contraception as determined by the physician of the patient throughout the study.

Exclusion criteria

* Minor Patient * Patients whose tumor resection is incomplete * Patients with an indication of mastectomy * Patients with a history of radiation therapy of the chest * Pregnant women, lactating, or of childbearing age without effective contraception. * Patients who had more than 4 scanners in one year. ( Scanner cervical , thoracic, or abdominal * Patients with an incompatible condition with monitoring protocol (psychiatric disorder, uncontrolled disease). * Patient unable to respond to a questionnaire

Design outcomes

Primary

Measure	Time frame
Quantitative Physics: dosimetric comparison of doses in target volumes and organs at risk	From baseline to 5 weeks

Secondary

Measure	Time frame
Quality of Life Questionnaire	Baseline and Follow up month 3, 12, 24 and 36

Countries

Martinique

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026